Scott Smith
Celgene’s COO heads to the exit
April 3, 2018Manufacturing and Production, Medical Communications, Sales and Marketing Celgene, Mark Alles, Scott Smith, biotech, drugs, pharma, pharmaceutical
Celgene has had a rough six months, its share price since the beginning of October has dropped from $146 to …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
